CXCR4 blockade sensitizes osteosarcoma to doxorubicin by inducing autophagic cell death via PI3K-Akt-mTOR pathway inhibition

Doxorubicin is one of the most frequently used chemotherapy drugs in the treatment of osteosarcoma (OS), but the emergence of chemoresistance often leads to treatment failure. C-X-C motif chemokine receptor 4 (CXCR4) has been demonstrated to regulate OS progression and metastasis. However, whether C...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Yu-Xin, Lv, Ji-Yang, Zhou, Zi-Fei, Xu, Tian-Yang, Yang, Dong, Gao, Qiu-Ming, Fan, Lin, Li, Guo-Dong, Yu, Hai-Yang, Liu, Kai-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8208619/
https://www.ncbi.nlm.nih.gov/pubmed/34080667
http://dx.doi.org/10.3892/ijo.2021.5229

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8208619/
https://www.ncbi.nlm.nih.gov/pubmed/34080667
http://dx.doi.org/10.3892/ijo.2021.5229

Ejemplares similares